Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension

NCT00185094 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00185094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on Insulin Sensitivity in Overweight and Obese Subjects With Hypertension
Lead sponsor
Daiichi Sankyo
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2004
Completion date
July 31, 2005
Enrollment
60
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, insulin resistance, metabolic syndrome